SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 364,166 shares at $27.38 ($9.9M) on 2022-11-08, disclosed to the SEC on 2022-11-09.
Open-market sale of $9.9M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.22 | 132,978 | $3.6M | 36.5% |
| 2 | $27.22 | 132,978 | $3.6M | 36.5% |
| 3 | $27.38 | 49,105 | $1.3M | 13.5% |
| 4 | $27.38 | 49,105 | $1.3M | 13.5% |
| Total | $27.26 avg | 364,166 | $9.9M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |